Serum antibody levels in human paragonimiasis before and after therapy with praziquantel.
Enzyme immunoassays (ELISA) and indirect haemagglutination (IHA) were used to determine IgG and IgE serum antibody levels in 43 patients from Ecuador before and after therapy with praziquantel. ELISA indicated infection more sensitively than IHA. The tendency of increasing antibody levels between the first and second month after therapy was more distinct when measured by IHA, whereas the decreases of antibody levels between the third and sixth month after treatment was more distinct when measured by ELISA. The IgG ELISA for detecting long persisting antibody was more sensitive than IHA.
D000906:Antibodies / Q000032:analysis*; D004797:Enzyme-Linked Immunosorbent Assay; D006386:Hemagglutination Tests; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007546:Isoquinolines / Q000627:therapeutic use*; D010237:Paragonimiasis / Q000188:drug therapy / Q000276:immunology*; D010238:Paragonimus / Q000276:immunology; D011223:Praziquantel / Q000627:therapeutic use*
D000906:Antibodies; D007074:Immunoglobulin G; D007546:Isoquinolines; D007073:Immunoglobulin E; D011223:Praziquantel